July 22, 2026 08:00 AM GMT Celldex Therapeutics Inc | North America Barzol Development in PN Discontinued; Lower PT What's Changed Celldex Therapeutics Inc (CLDX.O) From To Price Target $44.00 $40.00 | Stock Rating | | | Overweight | | | --- | --- | --- | --- | --- | | Industry View | | | Attractive | | | Price target | | | $40.00 | | | Shr price, close (Jul 21, 2026) | | | $35.66 | | | Mkt cap, curr (mm) | | | $2,799 | | | 52-Week Range | | | $40.30-19.72 | | | Fiscal Year Ending | | 12/25 12/26e 12/27e 12 ...